| Authors: |
Dopler A; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Alkan F; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Malka Y; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Kammen R; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Hoefakker K; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Taranto D; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kocabay N; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Mimpen I; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Ramirez C; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Malzer E; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands., Isaeva OI; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kerkhoff M; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Gangaev A; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Silva J; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Ramalho S; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Hoekman L; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Altelaar M; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Beijersbergen R; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands., Akkari L; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Yewdell JW; Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Kvistborg P; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Faller WJ; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: w.faller@nki.nl. |
